These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29433402)

  • 1. The effect of low-dose ovarian stimulation with HMG plus progesterone on pregnancy outcome in women with history of recurrent pregnancy loss and secondary infertility: a retrospective cohort study.
    Coccia ME; Rizzello F; Cozzolino M; Turillazzi V; Capezzuoli T
    Gynecol Endocrinol; 2018 Jun; 34(6):528-531. PubMed ID: 29433402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry.
    Dernoncourt A; Hedhli K; Abisror N; Cheloufi M; Cohen J; Kolanska K; McAvoy C; Selleret L; Ballot E; Mathieu d'Argent E; Chabbert Buffet N; Fain O; Kayem G; Mekinian A
    Hum Reprod; 2024 Sep; 39(9):1934-1941. PubMed ID: 38942601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
    Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
    Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
    Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values for the midluteal plasma progesterone concentration: evidence from human menopausal gonadotropin-stimulated pregnancy cycles.
    Sallam HN; Sallam A; Ezzeldin F; Agamia AF; Abou-Ali A
    Fertil Steril; 1999 Apr; 71(4):711-4. PubMed ID: 10202883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
    Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
    J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H; Huang G; Pei L; Zeng P; Luo X
    Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of a frequently used prediction model for ongoing pregnancy in couples with unexplained recurrent pregnancy loss.
    Youssef A; van der Hoorn MLP; Dongen M; Visser J; Bloemenkamp K; van Lith J; van Geloven N; Lashley EELO
    Hum Reprod; 2022 Mar; 37(3):393-399. PubMed ID: 34875054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromocryptin + gonadotropin vs. goserelin + gonadotropin in ovulation induction in patients with polycystic ovaries].
    De Vita V
    Minerva Ginecol; 1995 Mar; 47(3):93-7. PubMed ID: 7630516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
    Sallam HN; Sallam AN; Ezzeldin FE; Agamia AF; Abou-Ali AH
    Int J Fertil Womens Med; 2000; 45(4):285-91. PubMed ID: 10997485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss.
    Stephenson MD; McQueen D; Winter M; Kliman HJ
    Fertil Steril; 2017 Mar; 107(3):684-690.e2. PubMed ID: 28081870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.